In a report released today, Michael Cyprys from Morgan Stanley maintained a Hold rating on CME Group (CME – Research Report), with a price target of $196.00. The company’s shares opened today at $177.61.
According to TipRanks, Cyprys is a 4-star analyst with an average return of 5.7% and a 54.55% success rate. Cyprys covers the Financial sector, focusing on stocks such as Nasdaq, CME Group, and Intercontinental Exchange.
Currently, the analyst consensus on CME Group is a Moderate Buy with an average price target of $202.88, a 14.23% upside from current levels. In a report released on January 5, J.P. Morgan also maintained a Hold rating on the stock with a $187.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Based on CME Group’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $1.23 billion and a net profit of $679.6 million. In comparison, last year the company earned a revenue of $1.11 billion and had a net profit of $926.5 million
Based on the recent corporate insider activity of 134 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of CME in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
CME Group Inc., formerly known as Chicago Mercantile Exchange Holdings Inc, is the world’s leading derivatives marketplace, with it offering a wide range of futures and options products for risk management. These include equity indexes, interest rates, agricultural commodities, foreign exchange, energy, and metals. The company also offers clearing and settlement services for exchange-traded contracts, as well as for cleared over-the-counter derivatives transactions. It also provides a wide range of market data services such as live quotes, delayed quotes, historical data service and market reports.
Read More on CME:
- CME Group price target lowered to $220 from $226 at UBS
- CME Group upgraded to Outperform from Neutral at Credit Suisse
- CME Group says ADV increased 7% in December to 19.2M contracts
- CME Group price target lowered to $250 from $270 at Piper Sandler
- CME Group’s Micro WTI options volume surpasses 100K contracts traded